Thermo Fisher Scientific Inc. (TMO) Competitors & Peers
The 5 companies closest to Thermo Fisher Scientific Inc. on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| DHR | Competitor | $209.37 | P/E 37.3RSI 65Cap 147.2 B |
| IDXX | Peer | $592.24 | P/E 41.9RSI 63Cap 47.1 B |
| A | Peer | $149.50 | P/E 30.0RSI 74Cap 42.2 B |
| IQV | Peer | $242.60 | P/E 30.3RSI 68Cap 40.0 B |
| NTRA | Peer | $318.82 | RSI 72Cap 46.0 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- MRVISupplier
Own 10-K customer-concentration disclosure: ThermoFisherScientificInc = 43% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- DHRCompetitor
Top life-sci tools competition.
Model-inferred, unverified — treat as a lead, not evidence - OLINKPartner
Thermo Fisher acquired Olink Proteomics in July 2024 for ~$3.1B to expand proteomics with proximity extension assay (PEA) technology.
Model-inferred, unverified — treat as a lead, not evidence - OLINKMerger
Thermo Fisher acquired Olink Proteomics in July 2024 for ~$3.1B to expand proteomics with proximity extension assay (PEA) technology.
Model-inferred, unverified — treat as a lead, not evidence - TECHCompetitor
Both compete as leading global life sciences tools and diagnostics companies.
Model-inferred, unverified — treat as a lead, not evidence - BRKRCompetitor
Bruker competes with Thermo Fisher in mass spectrometry.
Model-inferred, unverified — treat as a lead, not evidence - REPLSupplier
Thermo Fisher supplies biological bioreactors, cell culture media, and lab single-use systems to Replimune's manufacturing facilities.
Model-inferred, unverified — treat as a lead, not evidence - AMGNSupplier
Thermo Fisher supplies bioprocessing equipment, single-use bioreactors, and analytical instruments critical to Amgen's biologics manufacturing.
Model-inferred, unverified — treat as a lead, not evidence - LLYSupplier
Thermo Fisher is a critical CDMO and CRO partner for Eli Lilly, supplying bioprocessing equipment, consumables, and contract manufacturing services.
Model-inferred, unverified — treat as a lead, not evidence - QTRXCompetitor
Thermo Fisher (with Olink) competes against Quanterix's Simoa single-molecule array technology in ultra-sensitive protein biomarker detection.
Model-inferred, unverified — treat as a lead, not evidence - ABBVSupplier
Thermo Fisher provides research instruments, mass spectrometers, and contract biomanufacturing services to AbbVie across its immunology and oncology pipelines.
Model-inferred, unverified — treat as a lead, not evidence - IBRXSupplier
Thermo Fisher supplies high-quality cell culture media, bioreactor systems, and consumables for Anktiva manufacturing.
Model-inferred, unverified — treat as a lead, not evidence - INDVSupplier
Thermo Fisher (via Patheon) supplies drug formulation, sterilisation, and packaging services for Indivior's product line.
Model-inferred, unverified — treat as a lead, not evidence - QTRXCompetitor
Thermo Fisher (following its acquisition of Olink) competes with Quanterix in high-multiplex proteomics and biomarker analysis solutions.
Model-inferred, unverified — treat as a lead, not evidence - TARSSupplier
Thermo Fisher (via Patheon) supplies clinical and commercial formulation, fill-finish, and packaging of Xdemvy.
Model-inferred, unverified — treat as a lead, not evidence - TVTXSupplier
Thermo Fisher (via Patheon) provides clinical and commercial drug manufacturing and packaging services.
Model-inferred, unverified — treat as a lead, not evidence - NVOSupplier
Thermo Fisher's CDMO unit assists Novo Nordisk with manufacturing components of the Wegovy supply chain.
Model-inferred, unverified — treat as a lead, not evidence